1. The diagnostic value of MRI in staging (non-)metastatic lymph nodes in patients with non-small cell lung cancer: a meta-analysis. Peerlings J, Troost E, Nelemans P, Cobben D, de Boer J, van Lier A, Hoffmann A, Beets-Tan R. Radiology.

  2. Should breathing adapted radiotherapy also be applied for right-sided breast irradiation? Essers M, Poortmans P, Hol S, Verschueren K, Cobben D. Acta Oncol.

  3. Emerging role MRI for radiotherapy treatment planning in lung cancer. Cobben D, de Boer H, Tijssen R, Rutten E, van Vulpen M, Peerlings J, Troost E, Hoffmann A, van Lier A. Technol Cancer Res Treat.

  4. Effect of radiotherapy and chemotherapy on bone marrow activity: a 18F-FLT-PET study. Agool A, Slart R, Thorp K, Glaudemans A, Cobben D, Been L, Burlage F, Elsinga P, Dierckx R, Vellenga E, Holter J. Nucl Med Commun. 2011.

  5. Positron emission tomography in patients with breast cancer using (18)F-3'-deoxy-3'-fluoro-l-thymidine ((18)F-FLT)-a pilot study. Been LB, Elsinga PH, de Vries J, Cobben D, Jager P, Hoekstra H, Suurmeijer A. Eur J Surg Oncol.

  6. Prognostic value of the standardized uptake value in esophageal cancer. van Westreenen HL, Plukker J, Cobben D, Verhoogt C, Groen H, Jager P. Am J Roentgenol.

  7. Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer. van Westreenen H, Cobben D, Jager P, van Dullemen H, Wesseling J, Elsinga P, Plukker J. J Nucl Med. 2005.

  8. [18F]FLT-PET in oncology: current status and opportunities. Been L, Suurmeijer A, Cobben D, Jager P, Hoekstra H, Elsinga P. Eur J Nucl Med Mol Imaging. 2004.

  9. Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer? Cobben D, Elsinga P, Hoekstra H, Suurmeijer A, Vaalburg W, Maas B, Jager PL, Groen H. J Nucl Med. 2004.

  10. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. van Waarde A, Cobben D, Suurmeijer AJ, Maas B, Vaalburg W, de Vries E, Jager P, Hoekstra H, Elsinga P. J Nucl Med. 2004.

  11. Detection and grading of soft tissue sarcomas of the extremities with (18)F-3'-fluoro-3'-deoxy-L-thymidine. Cobben D, Elsinga P, Suurmeijer A, Vaalburg W, Maas B, Jager P, Hoekstra H. Clin Cancer Res. 2004.

  12. 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET. Cobben D, van der Laan B, Maas B, Vaalburg W, Suurmeijer A, Hoekstra H, Jager P, Elsinga PH.J Nucl Med. 2004.

  13. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Bastiaannet E, Groen H, Jager P, Cobben D, van der Graaf W, Vaalburg W, Hoekstra H. Cancer Treat Rev. 2004.

  14. 3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma? Cobben D, Jager P, Elsinga P, Maas B, Suurmeijer A, Hoekstra H. J Nucl Med. 2003.

  15. Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma. Havenga K, Cobben D, Oyen W, Nienhuijs S, Hoekstra H, Ruers T, Wobbes T. Eur J Surg Oncol. 2003.

  16. New diagnostic techniques in staging in the surgical treatment of cutaneous malignant melanoma. Cobben D, Koopal S, Tiebosch A, Jager P, Elsinga P, Wobbes T, Hoekstra H. Eur J Surg Oncol. 2002.

  17. Differential effects of selective and non-selective NOS inhibition on renal arginine and protein metabolism during endotoxemia in rats. Hallemeesch M, Cobben D, Soeters P, Deutz N. Clin Nutr. 2002.

  18. Renal amino acid metabolism during endotoxemia in the rat. Hallemeesch MM, Cobben D, Dejong C, Soeters P, Deutz N. J Surg Res. 2000.

Scientific contribution to articles of Ehanced Recovery after Research (ERAS) Group

  1. To eat or not to eat: facilitating early oral intake after elective colonic surgery in the Netherlands. Maessen J, Hoff C, Jottard K, Kessels A, Bremers A, Havenga K, Oostenbroek R, von Meyenfeldt M, Dejong C; Dutch Breakthrough Project Perioperative Care; ERAS Clin Nutr. 2009.

  2. Life and death of the nasogastric tube in elective colonic surgery in the Netherlands. Jottard K, Hoff C, Maessen J, van Ramshorst B, van Berlo C, Logeman F, Dejong C.; Dutch Perioperative Breakthrough Project; ERAS Clin Nutr. 2009.

Letters to the editor

  1. In regard to Rodrigues et al “Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis. [Int J Radiat Oncol Biol Phys. 2015]”. Cobben D, Jager P. Int J Radiat Oncol Biol Phys.

  2. In regard to Wildhaber et al. The Kasai portoenterostomy for biliary atresia: A review of a 27-year experience with 81 patients [J Paed Surgery 2003]. Cobben D, Peeters P, Nap R. J Pediatr Surg. 2005.

  3. In regard to Barthel et al., 3′-Deoxy-3′-[18F]fluorothymidine as a New Marker for Monitoring Tumor Response to Antiproliferative Therapy in Vivo with Positron Emission Tomography. Cancer Res., 63: 3791–3798, 2003. Cobben D, Elsinga P, van Waarde A, Jager P. Cancer Research. 2004.